SCHEMBL13115472

SCHEMBL13115472

CCC(C[N+]1([N-]C(=O)c2ccccc2OC)CCCCC1)OC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 1/20 0.38
▸ APOBEC3A P31941 1/20 0.38
▸ APOBEC3G Q9HC16 1/20 0.38
▸ CTSD P07339 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ABCB1 P08183 2/20 0.35
▸ SLC18A3 Q16572 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ KDM2B Q8NHM5 1/20 0.33
▸ MTNR1A P48039 1/20 0.33
▸ MTNR1B P49286 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115474 0.92 ATM (0.36) CTSDSMN1; SMN2HTTNPC1MAPT
SCHEMBL13115467 0.89 ELANE (0.33) CTSDSMN1; SMN2HTTLMNANPC1
SCHEMBL13115478 0.89 NPC1 (0.39) SMN1; SMN2LMNANPC1MAPTMAPK1
SCHEMBL13115564 0.88 KCNK3 (0.34) CTSDSMN1; SMN2HTTMAPTPOLB
SCHEMBL13115470 0.86 MAPT (0.43) SMN1; SMN2LMNANPC1MAPTTP53
SCHEMBL13115533 0.84 NPC1 (0.39) CTSDSMN1; SMN2HTTLMNAABCB1
SCHEMBL3521719 0.79 CTSD (0.43) PABPC1APOBEC3AAPOBEC3GCTSDSMN1; SMN2
SCHEMBL13115460 0.77 MAPT (0.42) SMN1; SMN2LMNANPC1MAPTTP53
SCHEMBL13115462 0.77 L3MBTL1 (0.41) SMN1; SMN2HTTLMNANPC1MAPT
SCHEMBL13115542 0.74 ALDH1A1 (0.42) CTSDSMN1; SMN2LMNAABCB1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 — — US disclosed
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 — — US disclosed
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS MITSUI CHEMICALS, INC (JP) 2010-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS LTA4H, EPHX2, EPHX1 PABPC1 3992/4885APOBEC3A 2143/4885APOBEC3G 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback